Given that TNF-α and IL-6 as well as the NF-κB activation are crucial for the development of glucose intolerance and insulin resistance [22], [24], [38], our data support the notion that inhibition of inflammation-related NF-κB activation may be a promising strategy for the intervention of glucose intolerance. The gene discussed is NFKB1; the disease is Glucose intolerance.